Medical Research
(H30)
IRS Verified
DX Registered
990 on File
JOHN F FORTNEY CHARTIABLEPANCREATIC CANCER RESEARCH GROUP
Financial strength (30%)
60/100
Reliability (20%)
45/100
Effectiveness (25%)
33/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$38K
Total Revenue
$36K
Total Expenses
$42K
Net Assets
N/A
Employees
Revenue Sources
Program Expense Ratio
0.0%
Fundraising Efficiency
51.9%
Operating Reserve
14.08x
Liability-to-Asset
0.0%
Revenue Diversification
9.6%
Compared with Peers
FY 2024
Compared with 782 similar organizations
(United States, Medical Research, under $100K in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
0.0% | 78.0% |
P10P90
|
Bottom quarter |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
51.9% | 42.5% |
P10P90
|
Below median |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
14.1 mo | 38.9 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
9.6% | 100.0% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
6.6% | -0.9% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-11.8% | -6.4% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
5.7% | 15.4% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $38K | $36K | $42K | 0.0% | — |
| 2023 | $36K | $41K | $40K | 0.0% | — |
| 2022 | $38K | $642 | $45K | 0.0% | — |
| 2021 | $36K | $35K | N/A | — | 1 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.